Stockreport

Protagonist Therapeutics (PTGX): Evaluating Valuation After a 65% Year-to-Date Share Price Surge [Yahoo! Finance]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF Investors are taking notice of the company's solid revenue and net income growth, which helps fuel ongoing optimism. See our latest analysis for Protagonist Therapeuti [Read more]